pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·2 min read
save

STAT+: When it comes to women’s health, money talks

Women's health experts suggest a 'reverse pitch' approach to endometriosis, osteoporosis, and autoimmune treatments, stressing the profit potential.

Aug 26, 2026·read at STAT ↗

STAT PlusHealth When it comes to women’s health, money talks Market forces are driving the case to fund research and improve treatment By Elizabeth CooneyAug. 26, 2026 Elizabeth Cooney[email protected]Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22.

Manage alerts for this article Email this article Share this article The flip side of each new discovery about women’s health is a history of research neglect. Now, as federal funding becomes increasingly precarious, some advocates, academics, and executives are appealing to another incentive. It’s called the profit motive.

Advertisement If disparities in women’s health were fully addressed, a 2024 World Economic Forum report estimated, by 2040 that could boost global economic productivity annually by $1 trillion. In the U.S., that would mean recovering about $300 billion in lost economic productivity. STAT+ Exclusive Story Already have an account?

Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%!

Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In cardiovascular disease, chronic diseases, reproductive health, STAT+ Submit a correction requestReprints Elizabeth Cooney Cardiovascular Disease Reporter Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer.

Send tips on Signal at LizC.22. Recommended D.C. Diagnosis August 25, 2026 STAT Plus: How Trump’s funding cuts are reshaping the health system The Readout August 24, 2026 STAT Plus: Lady Gaga and her fiancé launch a biotech startup Advertisement Health Care Inc.

Newsletter August 24, 2026 STAT Plus: Public-sector purgatory, and a union-hospital fight Health August 24, 2026 Americans bought 12% less soda under new SNAP restrictions, study says The Readout August 21, 2026 STAT Plus: Are cancer patients getting too much drug? Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
388 words · retrieved 46m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 50m agoNewer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ showsSTAT
  • 1h agoOpinion: Medical aid in dying and the burden of choosing to liveSTAT
  • 1h agoOpinion: Many post-Dobbs abortion fears have not come to pass. What does that mean for advocates?STAT
  • 1h agoSTAT+: New treatments for common cardiovascular risk factor near the market, with billions at stakeSTAT
  • 13h agoSTAT+: Sword Health to acquire Headspace, according to filingSTAT